• About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • Consumer Products
    • Professional Products
    • Global Public Health Solutions
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • Media
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • Consumer Products
    • Professional Products
    • Global Public Health Solutions
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • Media
  • Contact
Ellume appoints Joanne Moss to its Board as Non-executive Director

Ellume appoints Joanne Moss to its Board as Non-executive Director

  • Posted by Ellume
  • On November 12, 2019

Brisbane, Australia – 12 November 2019

Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming ASX IPO.

Joanne is a highly experienced senior executive who has enjoyed a successful career in legal advisory and corporate governance.  Joanne’s latest executive role was as the Chief Legal and Corporate Affairs Officer with Pizza Hut Australia, a brand owned by Fortune 500 company, Yum!. In a Board-facing executive role and as a member of its audit and risk committee, Joanne has contributed to the company’s commercial transformation and digital disruption within its industry with her financial acumen, stakeholder engagement, data driven strategic planning,  focus on innovation and emerging technologies, leadership, respect for corporate social responsibility, and  steadfast dedication to the principles of integrity and ethics.

Previously a private practice lawyer at top tier international law firm Norton Rose Fulbright, Joanne advised international and domestic private, listed and government clients in both corporate advisory and dispute resolution across the corporate governance and M&A, banking and finance, major projects, energy and resources, and commercial teams.

Joanne is a conference speaker across industries on corporate governance, diversity and inclusion, innovation and emerging technologies, risk and crisis management, negotiation and leadership.  She is a keynote speaker at the upcoming Women in Pharma and Medical Leadership Summit and a speaker at the upcoming In-House Legal National Conference. 

Joanne was recently announced as a finalist for two ACC Australia Corporate Lawyer Awards and a Lawyers Weekly Women in Law Award. The winners are to be advised in November this year.

Joanne is admitted to the Supreme Courts of NSW and WA, and the High Court of Australia. She holds a Bachelor of Laws (Hons 1st), a Master of Laws in International Law (Distinction), a Certificate of Chinese Laws and Legal Systems in Shanghai, and has undertaken further studies at Oxford and the Governance Institute of Australia.

“I am pleased to welcome Joanne to Ellume’s Board of Directors. Joanne offers the Board a highly complementary skillset with other directors, and her wealth of governance, risk and compliance expertise will be instrumental in directing the Company through near-term commercialisation of its products, as well as a potential ASX-listing,” said Chairman Paul Darrouzet.

Ellume plans to commercialise its digital diagnostic product suite in multiple markets, for the fast and effective detection of high-burden diseases. It has signed commercialisation partnerships with leading global healthcare companies GlaxoSmithKline (GSK) and QIAGEN to launch and distribute its products.

ENDS

InvestorsMedia & General Inquiries
Dr Sean Parsons
Founder & Managing Director
E: sean.parsons@ellumehealth.com
T: +61 7 3393 1448
Taryn Silver
WE Communications
E: tsilver@we-buchan.com
M: +61 4 0108 1683
Recent Posts
  • Ellume appoints Joanne Moss to its Board as Non-executive Director
  • How Digital Diagnostics Are Changing Healthcare
  • Ellume shines at AFR BOSS’ Most Innovative Companies Awards
  • The 10 most innovative health companies
  • From the emergency ward to pitching an IPO
Archives
  • November 2019
  • October 2019
  • August 2019
  • June 2019
  • April 2019
  • January 2019
  • December 2018
Categories
  • Business

How Digital Diagnostics Are Changing Healthcare

Previous thumb
Scroll

ellume logo white

ABN 13 141 767 660
57 Didsbury Street,
East Brisbane, Queensland 4169
Australia

MENU

Home
About Us
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
Media

CONTACT US

1800 001 120
+61 7 3393 1448
General Enquiries
Privacy Policy

Ellume products pending regulatory clearance – NOT AVAILABLE FOR SALE © Ellume Limited 2019